Cost And Other Benefits Of OTCs To Over-65s

14 May 1995

Americans aged 65 and over use at least 25% of all over-the-counter products in the USA, even though they make up only 12.7% of the population, says the new edition of Aging and Health: The Role of Self-Medication, published by the US Nonprescription Drug Manufacturers Association.

One reason for this is that more conditions for which OTCs are used, such as arthritis, insomnia and constipation, become more prevalent with aging, says the study. The most frequently reported everyday health problems of older Americans are arthritis and rheumatism, sleeping problems, muscle aches and pains, upset stomach, overweight, headaches, colds and bunions/corns/callouses.

However, out of the estimated total of $938 billion spent on health care in the USA in 1994, almost $14 billion was accounted for by nonprescription medicines - less than two cents in every health care dollar. And the Bureau of Labor Statistics reports that in 1993, the average household headed by a person aged 65 or over spent $460 on prescription drugs, and only $108 on nonprescription drugs.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight